News & Perspective

May 08, 2013

May 08, 2013

Another death in China raises H7N9 fatalities to 32

(CIDRAP News) – Another patient in China has died from an H7N9 influenza infection, raising the number of fatal illnesses to 32, though no new cases were reported today, holding the overall case total to 131.

The World Health Organization (WHO) reported the death today in an update based on information from China's National Health and Family Planning Commission.

Apr 01, 2013

Apr 01, 2013

China reports three H7N9 infections, two fatal

(CIDRAP News) – Chinese health officials yesterday announced three severe respiratory infections, two of them fatal, from H7N9 influenza, a subtype that has not been known to infect humans before.

Mar 01, 2013

Mar 01, 2013

Study: Getting flu shot 2 years in a row may lower protection

(CIDRAP News) – Experts are puzzled by a new study in which influenza vaccination seemed to provide little or no protection against flu in the 2010-11 season—and in which the only participants who seemed to benefit from the vaccine were those who hadn't been vaccinated the season before.

Feb 24, 2012

Feb 24, 2012

Debate on H5N1 death rate and missed cases continues

(CIDRAP News) – Two leading voices on the potential threat of lab-modified H5N1 viruses laid out their arguments about the human H5N1 fatality rate and undetected cases today and yesterday, with one group claiming "millions" likely have been infected and the other group saying current World Health Organization (WHO) fatality-rate estimates are about right.

Oct 06, 2010

Oct 06, 2010

Trial answers some, not all, questions on cell-based flu vaccines

(CIDRAP News) – A new report says that a cell culture derived influenza vaccine and a conventional egg-based vaccine both proved effective in a large international clinical trial, offering support for those who contend that cell-based vaccines should become an important part of flu vaccine supplies in coming years.

Mar 31, 2009

Mar 31, 2009

Experts update businesses on antiviral stockpiling

(CIDRAP News) – Antiviral resistance and the global economic downturn might present new obstacles for corporate antiviral stockpiling, but two medical experts today said the medications are still quick, reliable tools that can help preserve business continuity in an influenza pandemic.

Jun 12, 2008

Jun 12, 2008

Baxter says cell-based H5N1 vaccine did well in trial

(CIDRAP News) – A pharmaceutical company is reporting good results in the first clinical trial of an H5N1 avian influenza vaccine that uses a whole, killed H5N1 virus grown in cell culture—a combination of techniques that entails some risk but may boost immune response and shorten production time.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jun 26, 2007

Jun 26, 2007

Diluting H5N1 vaccine may protect more people, study says

(CIDRAP News) – Limited supplies of prepandemic influenza vaccine may prevent more illness cases overall if they are administered to more people in lower-than-recommended doses, University of Hong Kong researchers contend in a study published this month in Public Library of Science (PLoS) Medicine.

Pages

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»